Nanologica
NICA | ST
Overview
Corporate Details
- ISIN(s):
- SE0005454873 (+2 more)
- LEI:
- 54930017L41C7P87LP22
- Country:
- Sweden
- Address:
- Forskargatan 20 G, 151 36 Södertälje
- Website:
- https://nanologica.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of other chemical products
Description
Nanologica is a life science tools company that develops, manufactures, and sells advanced consumables to pharmaceutical manufacturers. The company specializes in nanoporous silica particles for preparative chromatography. Its flagship product, NLAB Saga®, is a high-performance silica medium engineered for the large-scale purification of peptide drugs, such as insulin and GLP-1 analogues used in treating diabetes and obesity. NLAB Saga® offers superior mechanical and chemical stability, which increases purification efficiency and product lifetime, thereby enhancing productivity and reducing costs for drug producers. The company's mission is to improve global access to cost-effective medicines through its advanced purification technologies.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for Nanologica.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-07-10 08:10 |
Quarterly Report
|
Swedish | 828.6 KB | |
| 2025-07-10 08:10 |
Quarterly Report
|
English | 856.3 KB | |
| 2025-06-30 11:00 |
Declaration of Voting Results & Voting Rights Announcements
Antal aktier och röster i Nanologica AB (publ)
|
Swedish | 44.5 KB | |
| 2025-06-30 11:00 |
Share Issue/Capital Change
Number of Shares and Votes in Nanologica AB (publ)
|
English | 43.9 KB | |
| 2025-06-13 10:34 |
M&A Activity
UTTALANDE FRÅN STYRELSEN I NANOLOGICA AB (PUBL) MED ANLEDNING AV BUDPLIKTSERBJU…
|
Swedish | 51.9 KB | |
| 2025-06-13 10:34 |
M&A Activity
STATEMENT FROM THE BOARD OF DIRECTORS OF NANOLOGICA AB (PUBL) REGARDING THE MAN…
|
English | 50.7 KB | |
| 2025-06-12 08:14 |
Regulatory News Service
NANOLOGICA AB (PUBL) TAR ORDER OM CA 1,3 MSEK FRÅN NY KUND I USA
|
Swedish | 48.9 KB | |
| 2025-06-12 08:14 |
Regulatory News Service
NANOLOGICA AB (PUBL) RECEIVES ORDER OF APPX. SEK 1.3 MILLION FROM NEW CUSTOMER …
|
English | 48.6 KB | |
| 2025-05-23 16:41 |
Share Issue/Capital Change
Nanologica AB (publ) meddelar utfall av inlösen av teckningsoptioner av serie T…
|
Swedish | 41.2 KB | |
| 2025-05-23 16:41 |
Declaration of Voting Results & Voting Rights Announcements
Nanologica AB (publ) Announces the Outcome of the Exercise of Warrants of Serie…
|
English | 40.5 KB | |
| 2025-05-23 07:36 |
M&A Activity
Kommentar från styrelsen i Nanologica AB (publ) angående budpliktsbud från Fler…
|
Swedish | 48.3 KB | |
| 2025-05-23 07:36 |
Legal Proceedings Report
Comment from the Board of Nanologica AB (publ) Regarding the Mandatory Bid from…
|
English | 48.3 KB | |
| 2025-05-22 14:54 |
Post-Annual General Meeting Information
Bulletin from the AGM 2025 Nanologica AB (publ)
|
English | 48.0 KB | |
| 2025-05-22 14:54 |
Post-Annual General Meeting Information
Kommuniké årsstämma 2025 Nanologica AB (publ)
|
Swedish | 47.8 KB | |
| 2025-04-23 07:06 |
Regulatory News Service
Nanologica AB Receives Order Worth USD 180,000 from New Customer in China
|
English | 46.7 KB |
Automate Your Workflow. Get a real-time feed of all Nanologica filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Nanologica via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-10-01 | Alexandra Blomberg Montgomery | Other | Other | 447,628 | 1,007,163.00 SEK |
| 2024-10-01 | Alexandra Blomberg Montgomery | Other | Other | 69,008 | 155,268.00 SEK |
| 2024-10-01 | Alexandra Blomberg Montgomery | Other | Other | 48,300 | 108,675.00 SEK |
| 2024-10-01 | Alexandra Blomberg Montgomery | Other | Other | 917,641 | 2,064,692.25 SEK |
| 2024-10-01 | Alexandra Blomberg Montgomery | Other | Other | 72,507 | 163,140.75 SEK |
| 2024-10-01 | Alexandra Blomberg Montgomery | Other | Other | 351,631 | 791,169.75 SEK |
| 2024-10-01 | Alexandra Blomberg Montgomery | Other | Other | 37,000 | 83,250.00 SEK |
| 2022-10-10 | Tomas Kramar | Other | Buy | 16,600 | 166,000.00 SEK |
| 2022-10-10 | Tomas Kramar | Other | Buy | 10,000 | 100,000.00 SEK |
| 2022-10-05 | Sitbon Bioscience Partner ZENZ AB | Other | Buy | 6,666 | 66,660.00 SEK |
/other/Celanese_Corporation_Del.-logo.png){kind=logo}